rheumatology Archives -

Swiss pharma hopes to bounce back from Q1 sales disappointment

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Otezla cheap and convenient, but less effective than rivals, says NICE.

NICE says Otezla’s bargain price offsets lower efficacy

https://pharmaphorum.com/transversal-categories/uk-and-europe/nice-backs-celgenes-arthritis-pill/

R-Pharm has a mid-stage rival.

Russian rival to GSK/Janssen’s RA drug revealed

https://pharmaphorum.com/news/russian-rival-gskjanssens-ra-drug-revealed/

Gamble on opicinumab looks unlikely to pay off.

Biogen eyeing big-selling biosimilars as MS drug fails

https://pharmaphorum.com/news/biosimilars-increasingly-important-biogen/

But attendees warned to expect “oceanic” weather.

Janssen’s RA candidate among hot topics at EULAR

https://pharmaphorum.com/news/janssens-ra-candidate-among-hot-topics-eular/

rheumatology